On January 29, 2025 from 10am-3pm ET, the Foundation for Angelman Syndrome Therapeutics and the Angelman Syndrome Foundation will co-host Hope in Action: an Externally Led-PFDD Meeting on Angelman Syndrome. This meeting is a platform for our community to share insights and priorities directly with the FDA and other stakeholders, ultimately shaping the future of therapy development.
The meeting will be held virtually, you will be able to attend and participate from home.